Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Welgus Howard G. sold 4,731 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded Jun 15 to Jun 17, 2026 · Filed Jun 17, 2026
From Jun 15 to Jun 17, 2026, Welgus Howard G. (Director) sold 4,731 Arcutis Biotherapeutics, Inc. shares at an average US$24.58 for US$116K under a trading plan, leaving 37,743 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 4,731 shares
- Price
- US$24.58 average (US$24.41 to US$25.67)
- Value
- US$116K
- Holding after
- 37,743 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Option exercise | 822 | US$6.52 | 39,200 | Direct |
| Jun 15, 2026 | Common Stock | Option exercise | 1,019 | US$7.51 | 40,219 | Direct |
| Jun 15, 2026 | Common Stock | Option exercise | 2,255 | US$8.63 | 42,474 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 4,096 | US$24.41 | 38,378 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 635 | US$25.67 | 37,743 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Welgus Howard G.
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Welgus Howard G. · Aug 19, 2026
- Form 4 · Welgus Howard G. · Jul 17, 2026
- Form 4 · Welgus Howard G. · Jun 9, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026
- Form 4 · Curran Terrie · Aug 28, 2026
- Form 4 · Curran Terrie · Aug 24, 2026